Related Experiment Video
Updated: Jan 8, 2026

Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
Causes of Death in Patients with Cancer: A Scoping Review
Chien-Tzu Lee1,2, Yifeng Gao1,2, Volker Arndt1,3
1Unit of Cancer Survivorship, German Cancer Research Center, Heidelberg, Germany.
None:
With improved survival, noncancer causes of death have become increasingly relevant in cancer care. Excess noncancer mortality may reflect treatment-related toxicity, comorbidities, shared risk factors, and psychologic distress. This scoping review aimed to map the population-based evidence on the causes of death in patients with cancer and identify research gaps. PubMed, Web of Science, Cochrane Library, EMBASE, and Scopus were searched until April 2025. A total of 203 population-based studies using standardized mortality ratios (SMR) to compare cause-specific mortality among patients with cancer with that of the general population were included. Noncancer mortality was consistently elevated among patients with cancer [median SMR 1.60; interquartile range (IQR) 1.24-2.51], especially during the first year after diagnosis (3.42; 1.45-6.92), and remained higher over 10 years after diagnosis (1.51; 1.08-5.49). Younger patients and those with advanced-stage cancers demonstrated higher noncancer mortality. Among specific causes, cardiovascular disease (1.37; 1.09-2.34), suicide (1.73; 1.32-2.77), stroke (1.36; 0.98-2.17), infectious diseases in general (2.20; 1.35-4.16), septicemia (2.84; 1.64-5.47), and pneumonia/influenza (1.57; 1.08-2.69) were consistently elevated. Patients with cancer have demonstrated substantial noncancer mortality. These findings identify priority areas for targeted prevention and further investigation into cause-specific mortality patterns beyond cancer-related deaths to improve outcomes.
More Related Videos
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
10:03Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids
Published on: August 2, 2024
Related Concept Videos
Cancer Survival Analysis
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Kaplan-Meier Approach
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...